Results 271 to 280 of about 269,940 (298)
Some of the next articles are maybe not open access.
Baillière's Clinical Rheumatology, 1995
Assessing patients with SLE is difficult because of the heterogeneity of the disease. The Revised 1982 ARA Classification Criteria set has been widely accepted for classifying SLE patients for inclusion in clinical studies, but it is not appropriate for making the diagnosis of SLE in an individual and is not helpful for classifying patients with early ...
openaire +2 more sources
Assessing patients with SLE is difficult because of the heterogeneity of the disease. The Revised 1982 ARA Classification Criteria set has been widely accepted for classifying SLE patients for inclusion in clinical studies, but it is not appropriate for making the diagnosis of SLE in an individual and is not helpful for classifying patients with early ...
openaire +2 more sources
Angiology, 1970
Lupus is a serious, potentially life-threatening disease. Its natural history is to culminate in a crescendo of autoimmunity and organ involvement. Difficulty arriving at the diagnosis may delay institution of therapy, which although helpful brings new problems. The fundamental understanding of this disease has made major strides. There is no consensus
M, Brandsma, T H, Sternberg, J H, Davis
openaire +2 more sources
Lupus is a serious, potentially life-threatening disease. Its natural history is to culminate in a crescendo of autoimmunity and organ involvement. Difficulty arriving at the diagnosis may delay institution of therapy, which although helpful brings new problems. The fundamental understanding of this disease has made major strides. There is no consensus
M, Brandsma, T H, Sternberg, J H, Davis
openaire +2 more sources
New England Journal of Medicine, 1994
Systemic Lupus Erythematosus (SLE) is defined by its clinical features and by the almost invariable presence in the blood of antibodies directed against one or more components of cell nuclei.
openaire +2 more sources
Systemic Lupus Erythematosus (SLE) is defined by its clinical features and by the almost invariable presence in the blood of antibodies directed against one or more components of cell nuclei.
openaire +2 more sources
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Nature Medicine, 2022Andreas Mackensen, Sebastian Boeltz
exaly
Global epidemiology of systemic lupus erythematosus
Nature Reviews Rheumatology, 2021Megan R W Barber +2 more
exaly